Participants are able to take a more active role in their own health care, gain access to new drugs and treatments before they become widely available, and help other patients by contributing to medical research.
The Nebraska Medical Center participates in a variety of clinical trials to test new, investigational drugs or to study new ways of using known treatments. By researching the latest and most innovative transplant procedures and therapies, we can provide patients access to the newest treatments.
Once a patient has been evaluated and approved for transplant, they may be eligible for participation in a clinical trial. Patients deemed eligible to participate in a clinical trial will have the opportunity to review the study protocol to determine what is expected. The protocol will list details including the schedule of tests, procedures, medications, dosages, schedule of doctor appointments and the duration of the study.
Choosing to enroll in a research study is a personal decision. It requires careful consideration of the potential advantages and disadvantages. If a patient decides to participate in the study, they will be asked to sign an informed consent document. This document is not a contract, and the patient may withdraw at any time. The information on this page describes investigational programs the kidney/pancreas transplant program currently participates in to help advance transplantation success.
Please contact our Clinical Studies Program Coordinator regarding any questions or for further information regarding the available research studies:
Kris Seipel
402-559-6022
kseipel@unmc.edu
More information on any sponsored study is also available at www.clinicaltrials.gov
Pancreas Protocols:
Collaborative Islet Transplant Registry (CITR)
Principal Investigator:
R. Brian Stevens, MD, PhD
Description:
The purpose of this registry is to collect information on all people who have had an islet transplant done in the United States, Canada, and Europe since January 1, 1999. The reason for collecting this information is to advance progress and promote safety in islet transplantation through the collection, analysis, and communication of comprehensive and current information on all islet transplants.
Registry to Monitor Long-Term Outcome in Recipients of Kidney and/Or Pancreas Transplants.
Principal Investigator:
R. Brian Stevens, MD, PhD
Description:
The purpose of this registry is to monitor long term outcomes in recipients of kidney transplants and pancreas transplants.
Please contact our Clinical Studies Program Coordinator regarding any questions or for further information regarding the available research studies:
Kris Seipel
402-559-6022
kseipel@unmc.edu
More information on any sponsored study is also available at www.clinicaltrials.gov
Transplant Center
